[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fXWkMf0fh069AcfH0DfistUDeW6m5ZrkjpIrdQdx4LI4":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":43,"rows":50},"Michigan State University",[4],140,false,36,4,590357,2,124,[14,17,19,21,23,25,27,30],{"name":15,"count":16},"Stress",5,{"name":18,"count":16},"Anxiety",{"name":20,"count":9},"Autism Spectrum Disorder",{"name":22,"count":9},"Cancer",{"name":24,"count":9},"Breast Cancer",{"name":26,"count":9},"Obesity",{"name":28,"count":29},"Pregnancy",3,{"name":31,"count":29},"Depression",[33,38],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT05617365","Treating Chronic Cervicogenic Head and Neck Pain","2025-04-07","Osteopathic Manipulative Therapy and Exercise Therapy",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT07459504","SMART Diets for MASLD","2029-12-26","Essential Amino Acids Supplementation intervention",[44,45,46,47,48,49],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[51,77,99,126,144,171,196,222,247,273,291,322,340,358,376,394,412,438,463,488,516,534,560,584],{"intervention":37,"totalTrials":52,"cells":53},1,{"EARLY_PHASE1":54,"PHASE1":57,"PHASE2":59,"PHASE3":71,"PHASE4":73,"NA":75},{"trials":55,"activeCount":56},[],0,{"trials":58,"activeCount":56},[],{"trials":60,"activeCount":52,"soonestReadout":36},[61],{"nctId":34,"briefTitle":35,"status":62,"phases":63,"primaryCompletion":36,"completion":64,"start":65,"enrollment":66,"conditions":67,"interventions":70},"RECRUITING",[45,46],"2026-06-01","2022-09-01",30,[68,69],"Cervicogenic Headache","Neck Pain, Posterior",[37],{"trials":72,"activeCount":56},[],{"trials":74,"activeCount":56},[],{"trials":76,"activeCount":56},[],{"intervention":42,"totalTrials":52,"cells":78},{"EARLY_PHASE1":79,"PHASE1":81,"PHASE2":83,"PHASE3":93,"PHASE4":95,"NA":97},{"trials":80,"activeCount":56},[],{"trials":82,"activeCount":56},[],{"trials":84,"activeCount":52,"soonestReadout":41},[85],{"nctId":39,"briefTitle":40,"status":62,"phases":86,"primaryCompletion":41,"completion":87,"start":88,"enrollment":89,"conditions":90,"interventions":92},[46],"2030-12-26","2026-06",102,[91],"Metabolic-dysfunction Associated Steatotic Liver Disease",[42],{"trials":94,"activeCount":56},[],{"trials":96,"activeCount":56},[],{"trials":98,"activeCount":56},[],{"intervention":100,"totalTrials":52,"cells":101},"Intravenous sedation using propofol",{"EARLY_PHASE1":102,"PHASE1":104,"PHASE2":106,"PHASE3":108,"PHASE4":110,"NA":124},{"trials":103,"activeCount":56},[],{"trials":105,"activeCount":56},[],{"trials":107,"activeCount":56},[],{"trials":109,"activeCount":56},[],{"trials":111,"activeCount":56},[112],{"nctId":113,"briefTitle":114,"status":115,"phases":116,"primaryCompletion":117,"completion":118,"start":119,"enrollment":52,"conditions":120,"interventions":122},"NCT01712477","A Comparison of Propofol Versus Midazolam to Sedate Critically Brain Injury; Measurement of Cytokine Response and Assessment of Function","TERMINATED",[48],"2014-11","2014-12","2011-11",[121],"Traumatic Brain Injury",[100,123],"Intravenous sedation with midazolam",{"trials":125,"activeCount":56},[],{"intervention":123,"totalTrials":52,"cells":127},{"EARLY_PHASE1":128,"PHASE1":130,"PHASE2":132,"PHASE3":134,"PHASE4":136,"NA":142},{"trials":129,"activeCount":56},[],{"trials":131,"activeCount":56},[],{"trials":133,"activeCount":56},[],{"trials":135,"activeCount":56},[],{"trials":137,"activeCount":56},[138],{"nctId":113,"briefTitle":114,"status":115,"phases":139,"primaryCompletion":117,"completion":118,"start":119,"enrollment":52,"conditions":140,"interventions":141},[48],[121],[100,123],{"trials":143,"activeCount":56},[],{"intervention":145,"totalTrials":52,"cells":146},"human chorionic gonadotropin",{"EARLY_PHASE1":147,"PHASE1":149,"PHASE2":151,"PHASE3":153,"PHASE4":155,"NA":169},{"trials":148,"activeCount":56},[],{"trials":150,"activeCount":56},[],{"trials":152,"activeCount":56},[],{"trials":154,"activeCount":56},[],{"trials":156,"activeCount":56},[157],{"nctId":158,"briefTitle":159,"status":160,"phases":161,"primaryCompletion":162,"completion":162,"start":163,"enrollment":164,"conditions":165,"interventions":168},"NCT01786252","Effect of hCG on Receptivity of the Human Endometrium","COMPLETED",[48],"2016-03","2013-01",15,[166,167],"Infertility","Subfertility",[145],{"trials":170,"activeCount":56},[],{"intervention":172,"totalTrials":52,"cells":173},"13-valent conjugate pneumococcal vaccine",{"EARLY_PHASE1":174,"PHASE1":176,"PHASE2":178,"PHASE3":180,"PHASE4":182,"NA":194},{"trials":175,"activeCount":56},[],{"trials":177,"activeCount":56},[],{"trials":179,"activeCount":56},[],{"trials":181,"activeCount":56},[],{"trials":183,"activeCount":56},[184],{"nctId":185,"briefTitle":186,"status":160,"phases":187,"primaryCompletion":188,"completion":118,"start":189,"enrollment":190,"conditions":191,"interventions":193},"NCT01974817","Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease",[48],"2013-12","2013-05",25,[192],"End Stage Renal Disease",[172],{"trials":195,"activeCount":56},[],{"intervention":197,"totalTrials":52,"cells":198},"Doxycycline Hyclate",{"EARLY_PHASE1":199,"PHASE1":201,"PHASE2":203,"PHASE3":205,"PHASE4":207,"NA":220},{"trials":200,"activeCount":56},[],{"trials":202,"activeCount":56},[],{"trials":204,"activeCount":56},[],{"trials":206,"activeCount":56},[],{"trials":208,"activeCount":56},[209],{"nctId":210,"briefTitle":211,"status":160,"phases":212,"primaryCompletion":213,"completion":213,"start":214,"enrollment":215,"conditions":216,"interventions":219},"NCT05399290","Subantimicrobial Doxycycline in Acne",[48],"2021-11-08","2020-11-19",22,[217,218],"Acne Vulgaris","Pediatrics",[197],{"trials":221,"activeCount":56},[],{"intervention":223,"totalTrials":52,"cells":224},"Hypertonic saline",{"EARLY_PHASE1":225,"PHASE1":227,"PHASE2":229,"PHASE3":231,"PHASE4":243,"NA":245},{"trials":226,"activeCount":56},[],{"trials":228,"activeCount":56},[],{"trials":230,"activeCount":56},[],{"trials":232,"activeCount":56},[233],{"nctId":234,"briefTitle":235,"status":160,"phases":236,"primaryCompletion":237,"completion":237,"start":238,"enrollment":239,"conditions":240,"interventions":242},"NCT03300648","Treating Brain Swelling in Pediatric Cerebral Malaria",[47],"2023-12-31","2018-01-08",57,[241],"Malaria, Cerebral",[223],{"trials":244,"activeCount":56},[],{"trials":246,"activeCount":56},[],{"intervention":248,"totalTrials":52,"cells":249},"Saw Palmetto",{"EARLY_PHASE1":250,"PHASE1":252,"PHASE2":254,"PHASE3":267,"PHASE4":269,"NA":271},{"trials":251,"activeCount":56},[],{"trials":253,"activeCount":56},[],{"trials":255,"activeCount":56},[256],{"nctId":257,"briefTitle":258,"status":160,"phases":259,"primaryCompletion":260,"completion":260,"start":261,"enrollment":262,"conditions":263,"interventions":265},"NCT01585246","Saw Palmetto: Symptom Management for Men During Radiation Therapy",[45,46],"2015-04","2011-10",48,[264],"Prostate Cancer",[248,266],"soybean oil soft gel",{"trials":268,"activeCount":56},[],{"trials":270,"activeCount":56},[],{"trials":272,"activeCount":56},[],{"intervention":266,"totalTrials":52,"cells":274},{"EARLY_PHASE1":275,"PHASE1":277,"PHASE2":279,"PHASE3":285,"PHASE4":287,"NA":289},{"trials":276,"activeCount":56},[],{"trials":278,"activeCount":56},[],{"trials":280,"activeCount":56},[281],{"nctId":257,"briefTitle":258,"status":160,"phases":282,"primaryCompletion":260,"completion":260,"start":261,"enrollment":262,"conditions":283,"interventions":284},[45,46],[264],[248,266],{"trials":286,"activeCount":56},[],{"trials":288,"activeCount":56},[],{"trials":290,"activeCount":56},[],{"intervention":292,"totalTrials":52,"cells":293},"20 IU NovoLog Insulin aspart into the intranasal mucosa",{"EARLY_PHASE1":294,"PHASE1":296,"PHASE2":298,"PHASE3":316,"PHASE4":318,"NA":320},{"trials":295,"activeCount":56},[],{"trials":297,"activeCount":56},[],{"trials":299,"activeCount":56},[300],{"nctId":301,"briefTitle":302,"status":160,"phases":303,"primaryCompletion":304,"completion":304,"start":305,"enrollment":306,"conditions":307,"interventions":310},"NCT04292535","Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise",[46],"2020-02-20","2018-06-15",116,[308,309],"Insulin","Exercise",[292,311,312,313,314,315],"40 IU NovoLog Insulin aspart into the intranasal mucosa","60 IU NovoLog Insulin aspart into the intranasal mucosa","80 IU NovoLog Insulin aspart into the intranasal mucosa","100 IU NovoLog Insulin aspart into the intranasal mucosa","120 IU NovoLog Insulin aspart into the intranasal mucosa",{"trials":317,"activeCount":56},[],{"trials":319,"activeCount":56},[],{"trials":321,"activeCount":56},[],{"intervention":311,"totalTrials":52,"cells":323},{"EARLY_PHASE1":324,"PHASE1":326,"PHASE2":328,"PHASE3":334,"PHASE4":336,"NA":338},{"trials":325,"activeCount":56},[],{"trials":327,"activeCount":56},[],{"trials":329,"activeCount":56},[330],{"nctId":301,"briefTitle":302,"status":160,"phases":331,"primaryCompletion":304,"completion":304,"start":305,"enrollment":306,"conditions":332,"interventions":333},[46],[308,309],[292,311,312,313,314,315],{"trials":335,"activeCount":56},[],{"trials":337,"activeCount":56},[],{"trials":339,"activeCount":56},[],{"intervention":312,"totalTrials":52,"cells":341},{"EARLY_PHASE1":342,"PHASE1":344,"PHASE2":346,"PHASE3":352,"PHASE4":354,"NA":356},{"trials":343,"activeCount":56},[],{"trials":345,"activeCount":56},[],{"trials":347,"activeCount":56},[348],{"nctId":301,"briefTitle":302,"status":160,"phases":349,"primaryCompletion":304,"completion":304,"start":305,"enrollment":306,"conditions":350,"interventions":351},[46],[308,309],[292,311,312,313,314,315],{"trials":353,"activeCount":56},[],{"trials":355,"activeCount":56},[],{"trials":357,"activeCount":56},[],{"intervention":313,"totalTrials":52,"cells":359},{"EARLY_PHASE1":360,"PHASE1":362,"PHASE2":364,"PHASE3":370,"PHASE4":372,"NA":374},{"trials":361,"activeCount":56},[],{"trials":363,"activeCount":56},[],{"trials":365,"activeCount":56},[366],{"nctId":301,"briefTitle":302,"status":160,"phases":367,"primaryCompletion":304,"completion":304,"start":305,"enrollment":306,"conditions":368,"interventions":369},[46],[308,309],[292,311,312,313,314,315],{"trials":371,"activeCount":56},[],{"trials":373,"activeCount":56},[],{"trials":375,"activeCount":56},[],{"intervention":314,"totalTrials":52,"cells":377},{"EARLY_PHASE1":378,"PHASE1":380,"PHASE2":382,"PHASE3":388,"PHASE4":390,"NA":392},{"trials":379,"activeCount":56},[],{"trials":381,"activeCount":56},[],{"trials":383,"activeCount":56},[384],{"nctId":301,"briefTitle":302,"status":160,"phases":385,"primaryCompletion":304,"completion":304,"start":305,"enrollment":306,"conditions":386,"interventions":387},[46],[308,309],[292,311,312,313,314,315],{"trials":389,"activeCount":56},[],{"trials":391,"activeCount":56},[],{"trials":393,"activeCount":56},[],{"intervention":315,"totalTrials":52,"cells":395},{"EARLY_PHASE1":396,"PHASE1":398,"PHASE2":400,"PHASE3":406,"PHASE4":408,"NA":410},{"trials":397,"activeCount":56},[],{"trials":399,"activeCount":56},[],{"trials":401,"activeCount":56},[402],{"nctId":301,"briefTitle":302,"status":160,"phases":403,"primaryCompletion":304,"completion":304,"start":305,"enrollment":306,"conditions":404,"interventions":405},[46],[308,309],[292,311,312,313,314,315],{"trials":407,"activeCount":56},[],{"trials":409,"activeCount":56},[],{"trials":411,"activeCount":56},[],{"intervention":413,"totalTrials":52,"cells":414},"Fluoxetine",{"EARLY_PHASE1":415,"PHASE1":417,"PHASE2":419,"PHASE3":432,"PHASE4":434,"NA":436},{"trials":416,"activeCount":56},[],{"trials":418,"activeCount":56},[],{"trials":420,"activeCount":56},[421],{"nctId":422,"briefTitle":423,"status":160,"phases":424,"primaryCompletion":425,"completion":425,"start":426,"enrollment":427,"conditions":428,"interventions":431},"NCT05378711","Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine",[46],"2015-05-30","2014-01-01",6,[429,430],"Selective Mutism","Social Anxiety",[413],{"trials":433,"activeCount":56},[],{"trials":435,"activeCount":56},[],{"trials":437,"activeCount":56},[],{"intervention":439,"totalTrials":52,"cells":440},"Ceftazidime\u002Favibactam",{"EARLY_PHASE1":441,"PHASE1":443,"PHASE2":455,"PHASE3":457,"PHASE4":459,"NA":461},{"trials":442,"activeCount":56},[],{"trials":444,"activeCount":56},[445],{"nctId":446,"briefTitle":447,"status":160,"phases":448,"primaryCompletion":449,"completion":449,"start":450,"enrollment":451,"conditions":452,"interventions":454},"NCT02822950","A Study of Avycaz (Ceftazidime\u002FAvibactam) Pharmacokinetics\u002FPharmacodynamics (PK\u002FPD) in Critically Ill Patients",[45],"2017-12","2017-01",10,[453],"Pharmacokinetics of Avycaz in ICU Patients",[439],{"trials":456,"activeCount":56},[],{"trials":458,"activeCount":56},[],{"trials":460,"activeCount":56},[],{"trials":462,"activeCount":56},[],{"intervention":464,"totalTrials":52,"cells":465},"RTS,S\u002FAS01 malaria vaccine",{"EARLY_PHASE1":466,"PHASE1":468,"PHASE2":470,"PHASE3":472,"PHASE4":474,"NA":476},{"trials":467,"activeCount":56},[],{"trials":469,"activeCount":56},[],{"trials":471,"activeCount":56},[],{"trials":473,"activeCount":56},[],{"trials":475,"activeCount":56},[],{"trials":477,"activeCount":56},[478],{"nctId":479,"briefTitle":480,"status":160,"phases":481,"primaryCompletion":482,"completion":482,"start":483,"enrollment":484,"conditions":485,"interventions":487},"NCT04327440","RTSS Vaccine and PBO Net Impact on Malaria Infection and Transmission in Malawi",[],"2021-06-30","2020-02-04",1691,[486],"Malaria, Malaria Vaccine, Insecticide-treated Bednets",[464],{"intervention":489,"totalTrials":52,"cells":490},"Wolbachia induced incompatible mating",{"EARLY_PHASE1":491,"PHASE1":493,"PHASE2":495,"PHASE3":497,"PHASE4":499,"NA":501},{"trials":492,"activeCount":56},[],{"trials":494,"activeCount":56},[],{"trials":496,"activeCount":56},[],{"trials":498,"activeCount":56},[],{"trials":500,"activeCount":56},[],{"trials":502,"activeCount":56},[503],{"nctId":504,"briefTitle":505,"status":115,"phases":506,"primaryCompletion":507,"completion":507,"start":508,"enrollment":509,"conditions":510,"interventions":514},"NCT06595745","Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale",[49],"2025-01-31","2024-05-28",15243,[511,512,513],"Dengue","Zika","Chikungunya",[489,515],"Standard traditional chemical mosquito control",{"intervention":515,"totalTrials":52,"cells":517},{"EARLY_PHASE1":518,"PHASE1":520,"PHASE2":522,"PHASE3":524,"PHASE4":526,"NA":528},{"trials":519,"activeCount":56},[],{"trials":521,"activeCount":56},[],{"trials":523,"activeCount":56},[],{"trials":525,"activeCount":56},[],{"trials":527,"activeCount":56},[],{"trials":529,"activeCount":56},[530],{"nctId":504,"briefTitle":505,"status":115,"phases":531,"primaryCompletion":507,"completion":507,"start":508,"enrollment":509,"conditions":532,"interventions":533},[49],[511,512,513],[489,515],{"intervention":535,"totalTrials":52,"cells":536},"Influenza Vaccination",{"EARLY_PHASE1":537,"PHASE1":539,"PHASE2":541,"PHASE3":543,"PHASE4":545,"NA":547},{"trials":538,"activeCount":56},[],{"trials":540,"activeCount":56},[],{"trials":542,"activeCount":56},[],{"trials":544,"activeCount":56},[],{"trials":546,"activeCount":56},[],{"trials":548,"activeCount":56},[549],{"nctId":550,"briefTitle":551,"status":115,"phases":552,"primaryCompletion":553,"completion":553,"start":554,"enrollment":52,"conditions":555,"interventions":559},"NCT02296359","Vaccination Response in Individual Monozygotic Twins",[],"2015-08","2014-10",[556,557,558],"Individuality","Asthma","Immune System and Related Disorders",[535],{"intervention":561,"totalTrials":52,"cells":562},"levofloxacin at 250, 500, 750, and 1000 mg doses",{"EARLY_PHASE1":563,"PHASE1":565,"PHASE2":567,"PHASE3":569,"PHASE4":571,"NA":573},{"trials":564,"activeCount":56},[],{"trials":566,"activeCount":56},[],{"trials":568,"activeCount":56},[],{"trials":570,"activeCount":56},[],{"trials":572,"activeCount":56},[],{"trials":574,"activeCount":56},[575],{"nctId":576,"briefTitle":577,"status":160,"phases":578,"completion":579,"start":580,"enrollment":451,"conditions":581,"interventions":583},"NCT00376376","Urinary Bactericidal Activity of 4 Doses of Levofloxacin Against Fluoroquinolone-Resistant E. Coli",[49],"2006-11","2006-09",[582],"Healthy Volunteers",[561],{"intervention":585,"totalTrials":52,"cells":586},"Pneumococcal Vaccination",{"EARLY_PHASE1":587,"PHASE1":589,"PHASE2":591,"PHASE3":593,"PHASE4":595,"NA":597},{"trials":588,"activeCount":56},[],{"trials":590,"activeCount":56},[],{"trials":592,"activeCount":56},[],{"trials":594,"activeCount":56},[],{"trials":596,"activeCount":56},[],{"trials":598,"activeCount":56},[599],{"nctId":600,"briefTitle":601,"status":115,"phases":602,"primaryCompletion":603,"completion":603,"start":604,"enrollment":605,"conditions":606,"interventions":608},"NCT02654704","Vaccination Responses in Young and Older Adults",[],"2020-07","2015-11",61,[556,607,557,558],"Healthy",[585]]